General Motors Investment Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-13,103
Closed -$614K 796
2015
Q1
$614K Sell
13,103
-3,377
-20% -$134K 0.05% 395
2014
Q4
$522K Buy
16,480
+952
+6% +$27.9K 0.04% 477
2014
Q3
$368K Buy
+15,528
New +$398K 0.03% 583
2014
Q2
Sell
-21,862
Closed -$578K 1075
2014
Q1
$578K Buy
21,862
+2,016
+10% +$50.4K 0.05% 419
2013
Q4
$499K Sell
19,846
-447
-2% -$9.97K 0.04% 488
2013
Q3
$416K Buy
20,293
+3,444
+20% +$71.1K 0.04% 497
2013
Q2
$336K Buy
+16,849
New +$299K 0.03% 546

Other funds holding IPXL

General Motors Investment Management's IPXL Position: Q2 2015 in Review

General Motors Investment Management sold out of Impax Laboratories, Inc. (IPXL) in Q2 2015, closing a stake of 13,103 shares — an estimated $614K sold.

General Motors Investment Management first reported a position in IPXL in Q2 2013 and held it in 7 quarters. The position peaked at $614K in Q1 2015. 197 funds tracked by Wall St. Rank hold IPXL as of Q2 2015.

  • General Motors Investment Management reported no remaining Impax Laboratories, Inc. position as of Q2 2015 after selling out during the quarter.
  • General Motors Investment Management sold 13,103 Impax Laboratories, Inc. shares in Q2 2015, an estimated $614K.
  • General Motors Investment Management first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 7 quarters.
  • General Motors Investment Management's Impax Laboratories, Inc. position peaked at $614K in Q1 2015.
  • 197 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2015.

Based on General Motors Investment Management's 13F filing for Q2 2015, filed 5 Aug 2015.